← Back to Analyst Consensus 
GALT Buy
GALECTIN THERAPEUTICS INC
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 16, 2026 (20 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Dec 17, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Aug 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Apr 2, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Dec 27, 2024 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Aug 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Apr 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Apr 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Aug 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| May 17, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Mar 3, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $11 | 44% |
| May 17, 2022 | HC Wainwright & Co. | maintain | — → Buy | $11 | 44% |
| Apr 16, 2021 | HC Wainwright & Co. | maintain | — → Buy | $14 | 44% |
| Aug 13, 2020 | HC Wainwright & Co. | maintain | — → Buy | $12 | 44% |
| Apr 3, 2020 | B. Riley Securities | maintain | — → Buy | $4 | 54% |
| Mar 17, 2020 | HC Wainwright & Co. | maintain | — → Buy | $9 | 44% |
| Feb 13, 2019 | B. Riley Securities | initiate | — → Buy | $11 | 54% |
| Oct 19, 2017 | Roth Capital | initiate | — → Buy | $8 | 52% |
| Oct 6, 2017 | Seaport Global | initiate | — → Buy | $5 | 51% |
| Mar 30, 2017 | HC Wainwright & Co. | upgrade | Neutral → Buy | $3.5 | 44% |
| Oct 3, 2016 | FBR Capital | downgrade | Outperform → Market Perform | $0 | — |
| Sep 29, 2016 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Sep 28, 2016 | Roth Capital | downgrade | Buy → Sell | $0.75 | 52% |
| Sep 21, 2015 | HC Wainwright & Co. | initiate | — → Buy | $7 | 44% |
| Aug 1, 2014 | Aegis Capital | downgrade | Buy → Hold | $0 | — |
| Apr 2, 2014 | McNicoll Lewis Vlak | maintain | — → Buy | $27 | — |
| Feb 12, 2014 | Aegis Capital | maintain | — → Buy | $32 | — |
| Oct 7, 2013 | Ascendiant Capital | initiate | — → Buy | $13 | 37% |
| Jul 25, 2012 | Aegis Capital | initiate | — → Buy | $0 | — |
| Jul 6, 2012 | Dawson James | maintain | — → Buy | $3 | — |
Price Target Trend
Apr 13, 2026 Oct 27, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days